Frequency of HR-HPV Types in Patients with High Grade Cervical Intraepithelial Neoplasia (CIN)-Reference-Cited by-同舟云学术

Frequency of HR-HPV Types in Patients with High Grade Cervical Intraepithelial Neoplasia (CIN)

Published:2021-06-01 Issue:3 Volume:6 Page:122-127
ISSN:2645-3991
Container-title:Journal of Obstetrics, Gynecology and Cancer Research
language:en
Short-container-title:J Obstet Gynecol Cancer Res

Author:

Farzaneh Farah,Mohammadi Sama,Ghaffari Elnaz,Hosseini Afsaneh,Younesi Sarang,Taheri Amin Mohammad Mahdi,Balvayeh Payam,Navid Pour Fariba,Noori Ardebili Shahla, , , , , , , , ,

Publisher

Farname, Inc.

Subject

Obstetrics and Gynecology,Oncology,Embryology,Pediatrics, Perinatology and Child Health

Link

http://jogcr.com/article-1-355-en.pdf

Reference25 articles.

1. 1. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-48. 2. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-48. 3. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6): 518-527. 4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19. 5. Pim D, Thomas M, Banks L. The function of the human papillomavirus oncogenes. In: Viruses, Cell Transformation and Cancer Grand RJA (ed). Amsterdam: Elsevier; 2001. p. 145-192. 6. Hildesheim A. Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 1997; 89(11): 752-753. 7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010 Dec 15;127(12):2893-917. 8. Ferlay J ,Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013 Apr;49(6):1374-403. 9. WHO. Globocan 2012: estimated cancer incidence and mortality and prevalenc worldwide in 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. 10. Health IMo. Iran Cancer Report 2009. Tehran:Cancer Registration Office;2012. 11. Centers for Disease Control and Prevention. Gynecologic Cancers: Cervical cancer risk factors. Page last updated: September 3, 2013. Available from: http://www.cdc.gov/cancer/cervical/basic_info/risk_factors.htm 12. Karimy M, Hasani M, Khorram R, et al. The effect of education based on of Health Belief Model on breast self-examination in the health volunteers in Zarandieh. Tabibe Shargh: J Zahedan Univ Med Sci 2008; 10(4):79- 87. 13. Nojomi M, Modares M, Erfani A, et al. The frequency of cervical cancer risk factors in women referred to hospitals in Tehran, 2005-2006. J Iran Univ Med Sci 2007; 14(56): 189-95. 14. Austin LT, Farah A, Mary-Jane M, et al. Breast and cervical cancer screening in Hispanic women: a literature review using the Health Belief Model. Women Health Issues 2002; 12(3): 208-216. 15. Wong LP, Wong YL, Low WY, et al. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J 2009; 50(1): 49-53. 16. Tabeshian A, Firoozeh F. The effect of health education on performing Pap smear test for prevention of cervix cancer in teachers of Isfahan City. J Azad Univ Med Sci North Branch 2009; 19(1): 43-8. 17. Society of Family Planning of Islamic Republic of Iran. Public education of fertility health. Tehran: Andishmand publ; 2001: 6-49. 18. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1-30. 19. Bzhalava D. Human papillomavirus reference clones. International Human Papillomavirus Reference Center. Available at: URL: http://www.hpvcenter.se/html/refclones.html, consulté en septembre; 2014. 20. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012; 30(Suppl 5):F55-70. 21. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/35–41. 22. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014; 89(43):465-91. 23. Safaei A, Khanlari M, Momtahen M, Monabati A, Robati M, Amooei S, et al. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol 2010; 53(4):681-5. 24. Shahramian I, Heidari Z, Mahmoudzadeh-Sagheb H, Moradi A, Forghani F. Prevalence of HPV infection and high risk HPV genotypes (16, 18), among monogamous and polygamous women, in Zabol, Iran. Iran J Public Health 2011; 40(3):113–21. 25. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100(Pt B):1-441.

2. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-8.

3. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

4. The function of the human papillomavirus oncogenes